Class Action Lawsuit Reminder Against Bath & Body Works
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy BBWI?
Source: Globenewswire
- Class Action Notification: The Schall Law Firm reminds investors of a class action lawsuit against Bath & Body Works (NYSE:BBWI) for violations of securities laws during the period from June 4, 2024, to November 19, 2025, urging affected investors to contact the firm before March 16, 2026.
- False Statement Allegations: The complaint alleges that Bath & Body Works made false and misleading public statements during the class period, particularly failing to grow its customer base and net sales through its strategy of seeking 'adjacencies, collaborations, and promotions', resulting in investor losses.
- Failed Brand Collaboration Strategy: The company resorted to brand collaborations to 'carry quarters' despite weak financial results, which did not effectively improve its market performance and exacerbated investor losses.
- Legal Representation Information: The Schall Law Firm specializes in securities class action lawsuits and encourages affected shareholders to reach out to discuss their rights, emphasizing that investors are not represented until the class action is certified.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy BBWI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on BBWI
Wall Street analysts forecast BBWI stock price to fall
14 Analyst Rating
4 Buy
10 Hold
0 Sell
Moderate Buy
Current: 23.010
Low
15.00
Averages
20.14
High
26.00
Current: 23.010
Low
15.00
Averages
20.14
High
26.00
About BBWI
Bath & Body Works, Inc. is a global omnichannel retailer focused on personal care and home fragrance. The Company offers a range of fragrances for the body and home, including selling collections for 3-wick candles, home fragrance diffusers, fine fragrance mists, liquid hand soaps, body lotions and body creams. It delivers customers their fragrances in multiple forms and categories. The Company sells merchandise through its retail stores in the United States and Canada, and through its Websites and other channels, under the Bath & Body Works, White Barn and other brand names. The Company’s international business is conducted through franchise, license and wholesale partners. It provides in-store experiences at more than 1,890 Company-operated Bath & Body Works locations in the United States and Canada, more than 525 international franchised locations and an online storefront at bathandbodyworks.com. Additionally, it offers a buy online pick-up in-store (BOPIS) option.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Bath & Body Works Reports Decline in Q4 Profit
- Profit Decline: Bath & Body Works reported a fourth-quarter net profit of $403 million, or $1.99 per share, down from $453 million and $2.09 per share last year, indicating a weakening in the company's profitability.
- Adjusted Earnings: Excluding items, the company reported adjusted earnings of $415 million, or $2.05 per share, which, while slightly above expectations, still fails to offset the overall profit decline.
- Revenue Decrease: The company's fourth-quarter revenue fell to $2.724 billion, a 2.3% decrease from $2.788 billion last year, reflecting weakened market demand and increased competition.
- Future Guidance: The company provided a cautious EPS guidance range of $0.24 to $0.30 for the next quarter, indicating management's careful outlook on future performance, which may impact investor confidence.
See More
Class Action Lawsuit Reminder Against Bath & Body Works
- Class Action Notification: The Schall Law Firm reminds investors of a class action lawsuit against Bath & Body Works (NYSE:BBWI) for violations of securities laws during the period from June 4, 2024, to November 19, 2025, urging affected investors to contact the firm before March 16, 2026.
- False Statement Allegations: The complaint alleges that Bath & Body Works made false and misleading public statements during the class period, particularly failing to grow its customer base and net sales through its strategy of seeking 'adjacencies, collaborations, and promotions', resulting in investor losses.
- Failed Brand Collaboration Strategy: The company resorted to brand collaborations to 'carry quarters' despite weak financial results, which did not effectively improve its market performance and exacerbated investor losses.
- Legal Representation Information: The Schall Law Firm specializes in securities class action lawsuits and encourages affected shareholders to reach out to discuss their rights, emphasizing that investors are not represented until the class action is certified.
See More
Class Action Lawsuit Filed Against Bath & Body Works
- Lawsuit Background: Bragar Eagel & Squire has filed a class action lawsuit against Bath & Body Works in the Southern District of Ohio on behalf of investors who purchased securities between June 4, 2024, and November 19, 2025, with a deadline of March 16, 2026, to apply as lead plaintiffs.
- Financial Missteps: The complaint alleges that the company failed to disclose that its strategy of 'adjacencies, collaborations, and promotions' was not effectively growing its customer base, resulting in a 1% year-over-year revenue decline in Q3 2025, missing the 1-3% growth guidance, and a 26% drop in net income to $77 million.
- Stock Price Plunge: Following the disappointing financial results, Bath & Body Works' stock price fell by $5.22, or 24.8%, to close at $15.82 per share on November 20, 2025, indicating a negative market sentiment regarding the company's future prospects.
- Strategic Shift: The company acknowledged that its current strategy had failed to attract new customers and announced plans to exit certain adjacencies, focusing instead on core categories to improve performance and restore investor confidence.
See More
Bath & Body Works Exceeds Profit Expectations Despite Sales Decline
- Profit Beat: Bath & Body Works reported fourth-quarter adjusted EPS of $2.05, surpassing the market expectation of $1.336 billion, indicating resilience in profitability despite a 2% year-over-year sales decline.
- Divergent Sales Performance: Store sales in the U.S. and Canada fell 2.6% to $2.05 billion, while international sales rose 8.6% to $91 million, highlighting growth potential in international markets despite softness in core regions.
- Annual Performance Review: For fiscal year 2025, net sales were $7.291 billion, a slight decrease of 0.2%, with diluted EPS dropping from $3.61 to $3.11, reflecting a decline in profitability amid market challenges.
- Cautious Outlook: Bath & Body Works expects fiscal 2026 adjusted EPS between $2.40 and $2.65, below analysts' estimate of $2.80, and forecasts sales below market expectations, indicating uncertainty in future growth.
See More
Bath & Body Works Investors Urged to Act on Legal Rights
- Legal Investigation: Faruqi & Faruqi LLP is investigating potential claims against Bath & Body Works, Inc. for investors who purchased or acquired securities between June 4, 2024, and November 19, 2025, indicating possible legal risks for the company.
- Investor Rights Reminder: The firm reminds investors that March 16, 2026, is the deadline to seek the role of lead plaintiff in a federal securities class action, emphasizing the importance of timely action to protect their rights.
- Market Impact: The potential legal implications may pressure Bath & Body Works' stock price, prompting investors to monitor the company's future financial performance and legal developments to assess investment risks.
- Legal Consultation Access: Investors can contact Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) for more information regarding their legal rights.
See More
Bath & Body Works Reports Q4 Results Exceeding Guidance
- Q4 Sales Performance: Bath & Body Works reported net sales of $2.724 billion for Q4 2025, down 2% year-over-year, indicating increased market competition and reflecting challenges in the brand modernization process.
- Earnings Per Share: The company posted earnings per diluted share of $1.99 for Q4, down from $2.09 last year, although adjusted earnings were $2.05, demonstrating maintained profitability amid ongoing transformation efforts.
- 2026 Financial Guidance: For fiscal 2026, the company forecasts a net sales decline of 4.5% to 2.5%, with earnings per diluted share expected between $3.00 and $3.25, highlighting uncertainty in future market conditions while indicating strategic adjustments to address challenges.
- Share Repurchase Activity: In fiscal 2025, the company repurchased 15.1 million shares for $400 million, aiming to bolster shareholder confidence and enhance earnings per share despite facing sales declines.
See More
Bath & Body Works Reports Decline in Q4 Profit
- Profit Decline: Bath & Body Works reported a fourth-quarter net profit of $403 million, or $1.99 per share, down from $453 million and $2.09 per share last year, indicating a weakening in the company's profitability.
- Adjusted Earnings: Excluding items, the company reported adjusted earnings of $415 million, or $2.05 per share, which, while slightly above expectations, still fails to offset the overall profit decline.
- Revenue Decrease: The company's fourth-quarter revenue fell to $2.724 billion, a 2.3% decrease from $2.788 billion last year, reflecting weakened market demand and increased competition.
- Future Guidance: The company provided a cautious EPS guidance range of $0.24 to $0.30 for the next quarter, indicating management's careful outlook on future performance, which may impact investor confidence.
See More
Class Action Lawsuit Reminder Against Bath & Body Works
- Class Action Notification: The Schall Law Firm reminds investors of a class action lawsuit against Bath & Body Works (NYSE:BBWI) for violations of securities laws during the period from June 4, 2024, to November 19, 2025, urging affected investors to contact the firm before March 16, 2026.
- False Statement Allegations: The complaint alleges that Bath & Body Works made false and misleading public statements during the class period, particularly failing to grow its customer base and net sales through its strategy of seeking 'adjacencies, collaborations, and promotions', resulting in investor losses.
- Failed Brand Collaboration Strategy: The company resorted to brand collaborations to 'carry quarters' despite weak financial results, which did not effectively improve its market performance and exacerbated investor losses.
- Legal Representation Information: The Schall Law Firm specializes in securities class action lawsuits and encourages affected shareholders to reach out to discuss their rights, emphasizing that investors are not represented until the class action is certified.
See More
Class Action Lawsuit Filed Against Bath & Body Works
- Lawsuit Background: Bragar Eagel & Squire has filed a class action lawsuit against Bath & Body Works in the Southern District of Ohio on behalf of investors who purchased securities between June 4, 2024, and November 19, 2025, with a deadline of March 16, 2026, to apply as lead plaintiffs.
- Financial Missteps: The complaint alleges that the company failed to disclose that its strategy of 'adjacencies, collaborations, and promotions' was not effectively growing its customer base, resulting in a 1% year-over-year revenue decline in Q3 2025, missing the 1-3% growth guidance, and a 26% drop in net income to $77 million.
- Stock Price Plunge: Following the disappointing financial results, Bath & Body Works' stock price fell by $5.22, or 24.8%, to close at $15.82 per share on November 20, 2025, indicating a negative market sentiment regarding the company's future prospects.
- Strategic Shift: The company acknowledged that its current strategy had failed to attract new customers and announced plans to exit certain adjacencies, focusing instead on core categories to improve performance and restore investor confidence.
See More
Bath & Body Works Exceeds Profit Expectations Despite Sales Decline
- Profit Beat: Bath & Body Works reported fourth-quarter adjusted EPS of $2.05, surpassing the market expectation of $1.336 billion, indicating resilience in profitability despite a 2% year-over-year sales decline.
- Divergent Sales Performance: Store sales in the U.S. and Canada fell 2.6% to $2.05 billion, while international sales rose 8.6% to $91 million, highlighting growth potential in international markets despite softness in core regions.
- Annual Performance Review: For fiscal year 2025, net sales were $7.291 billion, a slight decrease of 0.2%, with diluted EPS dropping from $3.61 to $3.11, reflecting a decline in profitability amid market challenges.
- Cautious Outlook: Bath & Body Works expects fiscal 2026 adjusted EPS between $2.40 and $2.65, below analysts' estimate of $2.80, and forecasts sales below market expectations, indicating uncertainty in future growth.
See More
Bath & Body Works Investors Urged to Act on Legal Rights
- Legal Investigation: Faruqi & Faruqi LLP is investigating potential claims against Bath & Body Works, Inc. for investors who purchased or acquired securities between June 4, 2024, and November 19, 2025, indicating possible legal risks for the company.
- Investor Rights Reminder: The firm reminds investors that March 16, 2026, is the deadline to seek the role of lead plaintiff in a federal securities class action, emphasizing the importance of timely action to protect their rights.
- Market Impact: The potential legal implications may pressure Bath & Body Works' stock price, prompting investors to monitor the company's future financial performance and legal developments to assess investment risks.
- Legal Consultation Access: Investors can contact Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) for more information regarding their legal rights.
See More
Bath & Body Works Reports Q4 Results Exceeding Guidance
- Q4 Sales Performance: Bath & Body Works reported net sales of $2.724 billion for Q4 2025, down 2% year-over-year, indicating increased market competition and reflecting challenges in the brand modernization process.
- Earnings Per Share: The company posted earnings per diluted share of $1.99 for Q4, down from $2.09 last year, although adjusted earnings were $2.05, demonstrating maintained profitability amid ongoing transformation efforts.
- 2026 Financial Guidance: For fiscal 2026, the company forecasts a net sales decline of 4.5% to 2.5%, with earnings per diluted share expected between $3.00 and $3.25, highlighting uncertainty in future market conditions while indicating strategic adjustments to address challenges.
- Share Repurchase Activity: In fiscal 2025, the company repurchased 15.1 million shares for $400 million, aiming to bolster shareholder confidence and enhance earnings per share despite facing sales declines.
See More
